Biotricity raises $645,455 in third closing of Series B Preferred; total $2M private placement

BIOTRICITY INC.

Issued 71 shares of Series B Convertible Preferred to Ionic Ventures for $645,455 on May 15, 2024.
Combined with prior closings, total 220 Series B shares sold for $2M gross proceeds.
Filed amendment to Form S-3 to register 2,095,238 common shares issuable upon conversion.
Side letter waives 30-day limit on additional closings; company must deliver CA good-standing certificate within 10 days.
Stockholder approval required if conversions exceed Nasdaq rules; meeting to be held within 75 days of triggering event.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.